Responsiveness to Erythropoiesis-Stimulating Agents in Chronic Kidney Disease: Does Geography Matter? Luca De NicolaFrancesco LocatelliRoberto Minutolo Current Opinion 18 January 2014 Pages: 159 - 168
Does Treatment of Psoriasis Reduce the Risk of Cardiovascular Disease? Sarah ChurtonLiza BrownNeil J. Korman Leading Article 14 January 2014 Pages: 169 - 182
Acute Hyperglycemia Associated with Short-Term Use of Atypical Antipsychotic Medications T. Vivian LiaoStephanie V. Phan Review Article 08 January 2014 Pages: 183 - 194
Cobicistat: A Review of Its Use as a Pharmacokinetic Enhancer of Atazanavir and Darunavir in Patients with HIV-1 Infection Emma D. Deeks Adis Drug Evaluation 17 December 2013 Pages: 195 - 206
Afatinib: A Review of Its Use in the Treatment of Advanced Non-Small Cell Lung Cancer Gillian M. Keating Adis Drug Evaluation 17 January 2014 Pages: 207 - 221
Sitagliptin: A Review of Its Use in Patients with Type 2 Diabetes Mellitus Greg L. Plosker Adis Drug Evaluation 10 January 2014 Pages: 223 - 242
Rivaroxaban: A Review of Its Use in the Treatment of Deep Vein Thrombosis or Pulmonary Embolism and the Prevention of Recurrent Venous Thromboembolism Celeste B. BurnessCaroline M. Perry Adis Drug Evaluation 16 January 2014 Pages: 243 - 262
Ibrutinib: First Global Approval Fiona CameronMark Sanford R&D Insight Report 25 January 2014 Pages: 263 - 271
Sofosbuvir: First Global Approval Gillian M. KeatingAsha Vaidya R&D Insight Report 18 January 2014 Pages: 273 - 282